Status:
COMPLETED
Calcium for Prevention of Ovarian Hyperstimulation Syndrome
Lead Sponsor:
Cairo University
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
20-38 years
Phase:
PHASE3
Brief Summary
There are many protocols for prevention of ovarian hyperstimulation syndrome, intravenous calcium is a novel protocol. But still there is lack of evidence of it is real effect in prevention of OHSS \&...
Detailed Description
The study population will be divided into 2groups each containing 100 infertile couples candidate for ICSI. Group (A)active group: administration of 10% Intravenous calcium gluconate 10 ml in 200 mL ...
Eligibility Criteria
Inclusion
- infertile women aged 20 to 38 years.
- BMI ranged from 18 to 40.
- serum FSH within normal limits( 1-12IU /l)
- presented with ovarian response suggestive of being at risk of developing OHSS because of the presence of at least 15 follicles of 10 mm or greater on the day of hCG administration.
Exclusion
- endocrinopathies.
- a systemic disease.
- using any medication (e.g., insulin-sensitizing drugs and GnRH antagonists.
- patients need coasting for high risk of OHSS.
- patients need cycle cancellation.
- severe male infertility requiring testicular sperm extraction.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01427335
Start Date
October 1 2011
End Date
September 1 2013
Last Update
July 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr elini hospital
Cairo, Cario, Egypt, 12211